| 000 | 03349cam a22003615c 4500 | ||
|---|---|---|---|
| 001 | 85816 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040529.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 160425s2016 gw | s |||| 0|eng d | ||
| 020 | _a9783319313412 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRC280.P7 _b2016 EB |
|
| 082 | 0 | 4 | _a616.6 |
| 245 | 0 | 0 |
_aManaging Metastatic Prostate Cancer In Your Urological Oncology Practice _cedited by KC Balaji |
| 260 |
_aCham _bSpringer International Publishing _c2016 |
||
| 300 |
_a1 recurso en línea (XIII, 280 p.) _b35 ilustraciones, 31 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aIntroduction -- Pathophysiology of Castration-Resistant Prostate Cancer -- Androgen Receptor Signaling in Castration Resistant Prostate Cancer -- Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer -- Predictive Models in Castration Resistant Prostate Cancer -- Docetaxel in Advanced and Castration Resistant Prostate Cancer -- Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate -- Cancer Vaccines in Castration Resistant Prostate Cancer {u2014} An evolution in design -- Abiraterone for the treatment of mCRPC -- Enzalutamide in Metastatic Castration Resistant Prostate Cancer -- Radium-223 in Metastatic Castrate Resistant Prostate Cancer -- Cabazitaxel for the Treatment of Prostate Cancer -- Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer -- Bone Preservation Strategies for Men on Androgen Deprivation Therapy -- Novel Therapies in Castration-Resistant Prostate Cancer | |
| 520 | 3 | _aThis text provides a comprehensive review of pathophysiology, molecular and cell biology aspects of CRPC, discusses all major clinical trials that have led to approval of 6 new drugs since 2004, explores the role of bone preservation strategies, in depth analysis of combination and sequencing strategies, outlines upcoming novel drugs and trends in research, and stresses the role of palliative care in this incurable disease. Managing Metastatic Prostate Cancer in Your Urological Oncology Practice will serve as a very useful resource for physicians and researchers dealing with, and interested in prostate cancer. It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and will include the most up to date scientific and clinical information | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aPróstata _xCáncer _0comprobar BNE19901355947 _2embne _9182337 |
|
| 700 | 1 |
_aBalaji, K. C. _eeditor literario _0Local _999047 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-31341-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783319313412 | ||
| 907 |
_a.b12950944 _b10-10-17 _c21-11-16 |
||
| 988 | _aSpringer_Medicine_2016 | ||
| 998 |
_am _a_alco _a_vill _b04-04-17 _cm _dz _ek _feng _ggw _h0 |
||
| 945 |
_aRC280.P7 M363 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11593908 _z06-04-17 |
||
| 999 |
_c85816 _d85816 _x1 |
||